A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators
2008
Study on EpCAM and Cell Proliferation in Cancer Cells
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Maaser K, Borlak J
Primary Institution: Fraunhofer Institute of Toxicology and Experimental Medicine
Hypothesis
Does the EpCAM antibody induce cell proliferation in various carcinoma cell lines?
Conclusion
The study found that treatment with the EpCAM antibody increased cell proliferation in certain cancer cell lines.
Supporting Evidence
- EpCAM expression is upregulated in various carcinomas.
- Treatment with the EpCAM antibody increased cell proliferation in mouse and human lung carcinoma cells.
- Gene expression analysis revealed modulation of cell cycle regulators upon EpCAM antibody treatment.
Takeaway
This study looked at how a special antibody affects cancer cells, showing that it can make some of them grow faster.
Methodology
The study used various cancer cell lines and treated them with an EpCAM antibody, measuring cell proliferation and gene expression changes.
Limitations
The study primarily focused on in vitro models, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website